Breast cancer and the immune system: opportunities and pitfalls.
The identification of tumor-associated antigens, and advances in our understanding of human immunology, have resulted in renewed interest in tumor immunology. A variety of approaches have been utilized in recent years against different tumor types. The results from some of these studies have been encouraging, but it is not yet clear whether they will be applicable to patients with breast cancer.
Plunkett
T A
TA
ICRF Breast Cancer Biology Group, Guy's Hospital, London, United Kingdom.
Correa
I
I
Miles
D W
DW
Taylor-Papadimitriou
J
J
D000328:Adult; D001943:Breast Neoplasms / Q000276:immunology* / Q000473:pathology; D019496:Cancer Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003713:Dendritic Cells / Q000276:immunology / Q000502:physiology; D005260:Female; D006801:Humans; D007107:Immune System / Q000502:physiology*; D008207:Lymphatic Metastasis / Q000276:immunology; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008875:Middle Aged
D019496:Cancer Vaccines